Furthermore, in vitro cellular experiments were conducted to evaluate the suppression of KRAS expression attained by the various ASOs in NCI-H460 human adenocarcinoma cells without the use of transfection reagents. The gene discussed is KRAS; the disease is adenocarcinoma.